Advertisement
Canada markets closed
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7323
    -0.0001 (-0.01%)
     
  • CRUDE OIL

    83.88
    +0.31 (+0.37%)
     
  • Bitcoin CAD

    87,402.64
    -728.16 (-0.83%)
     
  • CMC Crypto 200

    1,388.79
    +6.22 (+0.45%)
     
  • GOLD FUTURES

    2,339.80
    -2.70 (-0.12%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,756.75
    +189.25 (+1.08%)
     
  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    37,618.29
    -10.19 (-0.03%)
     
  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Rexnord (RXN) Surges: Stock Moves 5.7% Higher

Rexnord Corporation RXN was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $19.34 –$25.82 in the past one-month time frame, witnessed a sharp increase on Friday.

The company has seen a mixed track record when it comes to estimate revision of one increase and one decrease over the past few weeks, while the Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Rexnord currently has a Zacks Rank #4 (Sell) while its Earnings ESP is negative.

Rexnord Corporation Price

Rexnord Corporation Price
Rexnord Corporation Price

Rexnord Corporation price | Rexnord Corporation Quote

ADVERTISEMENT

A better-ranked stock in the Manufacturing - Electronics industry is AZZ Inc. AZZ, which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
AZZ Inc. (AZZ) : Free Stock Analysis Report
 
Rexnord Corporation (RXN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research